info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Sugar-Based Excipients Market By Product Type (Sucrose, Mannitol, Sorbitol, Isomalt, Others); By Functionality (Binders, Fillers, Diluents, Flavoring Agents); By Application (Pharmaceuticals, Nutraceuticals, Food & Beverage, Veterinary); By End User (Pharmaceutical Companies, Generic Manufacturers, Nutraceutical Brands, Contract Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sugar-Based Excipients Market valued at USD 900 million in 2024 and projected to reach USD 1.4 billion by 2030 at 7.5% CAGR, driven by pharmaceuti... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Microbiological Testing of Water Market By Test Type (Culture-Based, PCR/Molecular, Immunoassays, Rapid/Field-Based); By Sample Source (Drinking Water, Wastewater, Industrial Process Water, Recreational Water); By End User (Municipal Utilities, Food & Beverage, Healthcare, Contract Labs, Hospitality); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microbiological Testing Of Water Market projected to reach USD 3.2 billion by 2030 from USD 2.1 billion in 2024, reflecting 7.5% CAGR, supported by Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Dosage Cups Market by Material Type (Plastic, Biodegradable, Fiber-Based); By Capacity (<10 mL, 10-20 mL, >20 mL); By Distribution Format (Bundled with Medication, Standalone Packs, Institutional Supply); By End User (Pharmaceutical Manufacturers, Retail Pharmacies, Hospitals, Homecare Providers, E-Commerce); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dosage Cups Market is projected to expand steadily at a CAGR of 5.8%, valued at approximately USD 1.32 billion in 2024, and likely to reach around Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Expression Vectors Market By Vector Type (Viral Vectors, Non-Viral Vectors); By Application (Therapeutics, Research & Development, Industrial Biotechnology, Agricultural Biotechnology); By End User (Biopharmaceutical Companies, Academic & Research Institutes, CROs, Industrial Biotechnology Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Expression Vectors Market valued at USD 4.8 billion in 2024 and projected to reach USD 8.2 billion by 2030 at 9.5% CAGR, driven by gene therapyRead More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Dual-energy X-ray Absorptiometry Market By Product Type (Central DEXA, Peripheral DEXA); By Application (Osteoporosis Diagnosis, Fracture Risk Assessment, Therapy Monitoring, Research & Preventive Health); By End User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dual-energy X-ray Absorptiometry Market growing at 6.5% CAGR, expanding from USD 3.2 billion in 2024 to USD 4.8 billion by 2030, fueled by osteopo... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Medical Membranes Market By Membrane Type (Polymeric, Ceramic, Composite, Others); By Application (Hemodialysis, Drug Delivery, Wound Care, Filtration, Others); By End User (Hospitals, Pharmaceutical & Biotech Companies, Research Institutes, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medical Membranes Market valued at USD 5.8 billion in 2024 and projected to reach USD 8.1 billion by 2030 at 6.5% CAGR, driven by medical devices<... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Bacteriological Testing Market By Testing Method (Culture Based Testing, Molecular Diagnostics, Immunological Methods, Automated Testing Systems); By Application (Food and Beverage Testing, Water and Environmental Testing, Pharmaceutical Testing, Clinical Diagnostics); By Sample Type (Raw Materials, Finished Products, Environmental Swabs, Water Samples); By End User (Food Producers, Water Utilities and Municipal Services, Pharmaceutical Manufacturers, Clinical Laboratories, Contract Testing Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

What Is the Bacteriological Testing Market Size and How Are Rapid Diagnostics Reshaping Clinical Microbiology?  – (Updated On: 24-Aug-2026)

The Global Bacteriological Testing Market was valued at USD 25.40 billion in 2025 and is projected to reach USD ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Digital Hearing Aids Market By Product Type (Behind-the-Ear, In-the-Ear, Receiver-in-Canal, Completely-in-Canal); By Technology Features (AI-based, Bluetooth Connectivity, Rechargeable, Noise Reduction); By End User (Geriatric Patients, Adults with Progressive Hearing Loss, Pediatric Users, Professional Users); By Distribution Channel (Audiology Clinics, Retail Outlets, Online Platforms, Hospitals/ENT Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Digital Hearing Aids Market is projected to witness a robust CAGR of 6.8%, valued at an 2024 market size of USD 10.2 billion and expected to reach around USD 15.2 ... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Internal Neuromodulation Devices Market By Product (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral and Tibial Neuromodulation Devices, Vagus Nerve and Responsive Neurostimulation Systems, Hypoglossal Nerve Stimulators); By Application (Chronic Pain, Parkinson Disease and Movement Disorders, Epilepsy, Urinary and Fecal Dysfunction, Obstructive Sleep Apnea); By End User (Hospitals, Ambulatory Surgical Centers, Neurology Clinics, Pain Management Clinics, Specialty Urology and Sleep Centers); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

The Internal Neuromodulation Devices Market Is Getting a Stronger Commercial Signal

Acquisitions, adaptive implants and new treatment pathways are expanding the commercial scope of neuromodulation, although patient selection, specialist capacity and reimbursement ... Read More

Published Date: JUL-2026 | No Of Pages:200 | $ 4485

Pharmaceutical Grade Sodium Chloride Market By Form (Powdered Crystalline, Solution – Injection-Ready); By Application (Parenteral/IV, Dialysis, Oral/Nasal Therapeutics); By End User (Pharmaceutical Companies, Hospitals, Dialysis Centers, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Grade Sodium Chloride Market valued at USD 1.18 billion in 2024 and projected to reach USD 1.72 billion by 2030 at 6.5% CAGR, driven by Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Performance Enhancing Drugs Market By Product Type (Anabolic Agents, Peptide Hormones, Stimulants, Nootropics, Beta-2 Agonists); By Application (Athletic Performance, Bodybuilding & Aesthetics, Cognitive Enhancement); By Distribution Channel (Prescription-Based, OTC Supplements, Black/Grey Market); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Performance Enhancing Drugs Market growing at 6.3% CAGR, expanding from USD 19.1 billion in 2024 to USD 27.6 billion by 2030, fueled by athletic p... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Glycinates Market By Product Type (Magnesium Glycinate, Zinc Glycinate, Calcium Glycinate, Iron Glycinate, Copper Glycinate, Manganese Glycinate); By Application (Animal Feed, Dietary Supplements, Pharmaceuticals, Personal Care); By End User (Feed Manufacturers, Nutraceutical Companies, Pharmaceutical Companies, Cosmetic Brands); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Glycinates Market valued at USD 987 million in 2024 and projected to reach USD 1.34 billion by 2030 at 5.3% CAGR, driven by nutritional supplement... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Chondroplasty Market by Procedure Type (Arthroscopic Chondroplasty, Microfracture Surgery, OAT, ACI); by End User (Hospitals, Orthopedic Surgery Centers, Ambulatory Surgical Centers); by Region (North America, Europe, Asia Pacific, LAMEA); Market Size, Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chondroplasty Market will witness a robust CAGR of 6.5% , valued at USD 3.5 billion in 2024, expected to appreciate and reach USD... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Nerve Repair Biomaterials Market by Product Type (Nerve Conduits, Nerve Wraps, Hydrogels, Nerve Guides with Electrical Integration); by Application (Peripheral Nerve Injury, Spinal Cord Injury, Facial Nerve Repair, Other Applications); by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutions); by Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nerve Repair Biomaterials Market valued at USD 1.36 billion in 2024 and projected to reach USD 2.29 billion by 2030 at 9.1% CAGR, driven by nerve ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Macrolide Antibiotics Market By Drug Type (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Nafithromycin, Others); By Application (Respiratory Tract Infections, Clostridioides difficile Infection, Skin and Soft Tissue Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Others); By Route of Administration (Oral, Intravenous, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation and Forecast, 2026–2032.

Macrolide Antibiotics Market: High Prescription Volume Persists as Resistance Redirects Commercial Value

The Global Macrolide Antibiotics Market is projected to grow from USD 6.15 billion in 2025 to USD 8.15 billion by 2032, expanding at a CAGR of 4.1%, according to S... Read More

Published Date: JUL-2026 | No Of Pages:197 | $ 4485

Digital Patient Monitoring Devices Market By Product (Continuous Glucose Monitoring Devices; Cardiac Monitoring Devices; Blood Pressure Monitoring Devices; Respiratory Monitoring Devices; Multiparameter Monitoring Devices; Weight and Activity Monitoring Devices; Implantable Hemodynamic Monitoring Devices); By Application (Diabetes Management; Cardiovascular Monitoring; Respiratory Disease Monitoring; Post-Operative and Post-Discharge Monitoring; Other Chronic Disease Monitoring); By End User (Home Care Settings, Hospitals, Ambulatory Care Centers, Specialty Clinics, Physician Practices, Long-Term Care and Rehabilitation Facilities); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Digital Patient Monitoring Devices Market: Market Overview and Strategic Context

The Global Digital Patient Monitoring Devices Market was valued at USD 15.95 billion in 2025 and is projected to reach USD 28.21 billion by 2032, growing at a CAGR of 8.5% from 2025 to 20... Read More

Published Date: JUL-2026 | No Of Pages:176 | $ 4485

Body Slimming Devices Market By Product Type (Cryolipolysis, Radiofrequency Devices, High-Intensity Focused Ultrasound, Laser Lipolysis, Ultrasonic Cavitation); By Application (Fat Reduction, Body Contouring, Skin Tightening, Cellulite Reduction); By End User (Cosmetic Clinics, Hospitals, Wellness Spas, Fitness Studios, Home-Use Consumers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Body Slimming Devices Market: The Multi-Billion-Dollar Revolution in Non-Invasive Body Contouring Technologies

The Global Body Slimming Devices Market is projected to experience a robust CAGR of 8.3%, valued at an estimated USD 2.1 billion in 2025, and expected to rea... Read More

Published Date: AUG-2026 | No Of Pages:197 | $ 4485

Oxytocic Pharmaceuticals Market By Drug Type (Oxytocin, Misoprostol, Carbetocin, Ergometrine); By Route of Administration (Injectable, Oral, Sublingual/Buccal/Rectal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Government & NGO Supply Chains); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oxytocic Pharmaceuticals Market growing at 5.6% CAGR, expanding from USD 185.4 million in 2024 to USD 257.4 million by 2030, fueled by maternal he... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Dental Splints Market By Product Type (Therapeutic Splints, Protective Splints, Diagnostic Splints); By Application (TMJ Disorders, Bruxism, Sleep Apnea, Orthodontics, Others); By End User (Dental Clinics, Hospitals, Orthodontists, Private Practices, Sports Dentists, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dental Splints Market is expected to experience substantial growth, driven by increasing awareness of oral health and advancements in dental technology. Valued at USD 2.5 billionRead More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Farm Animal Drug Market By Product Type (Antimicrobials, Vaccines, Parasiticides, Anti-Inflammatory Drugs, Feed-Additive Medicines, Others); By Animal Type (Poultry, Swine, Cattle, Aquaculture, Companion Livestock); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, Online Channels, Institutional Procurement); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Farm Animal Drug Market: Antimicrobial Stewardship, Vaccine-Led Prevention, Residue Compliance, and Livestock Productivity Redefine Veterinary Medicine Demand

The Global Farm Animal Drug Market was valued at USD 22.4 billion in 2025 and is projected to reach USD 35.5 ... Read More

Published Date: JUL-2026 | No Of Pages:181 | $ 4485

Widefield Imaging Systems Market By Technology (OCT, Fundus Cameras, Fluorescence Imaging, Widefield Microscopes, Portable Imaging Systems); By Application (Ophthalmology, Neurology, Cardiology, Oncology, Other Applications); By End User (Hospitals, Research Institutions, Clinics, ASCs, Military & Forensics); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Widefield Imaging Systems Market valued at USD 1.5 billion in 2024 and projected to reach USD 3.5 billion by 2030 at 15.2% CAGR, driven by ophthal... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Departmental Picture Archiving & Communication System (PACS) Market By Deployment Type (On-Premise, Cloud-Based); By Departmental Application (Radiology, Cardiology, Oncology, Orthopedics); By End User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Departmental Picture Archiving And Communication System (PACS) Market is poised to witness a robust CAGR of 6.8%, valued... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cosmetic Dentistry Market By Procedure Type (Teeth Whitening, Veneers, Dental Implants, Orthodontics, Others); By End User (Private Dental Clinics, Dental Service Organizations [DSOs], Hospital-Affiliated Dental Departments); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cosmetic Dentistry Market valued at USD 23.5 billion in 2024 and projected to reach USD 47.1 billion by 2030 at 12.3% CAGR, driven by dental impla... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Extreme Lateral Interbody Fusion (XLIF) Surgery Market By Procedure Type (Single-Level, Multi-Level); By Implant Type (Cages, Screws, Fixation Systems); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Extreme Lateral Interbody Fusion ( XLIF ) Surgery Market is projected to witness a robust CAGR of 8.1%, valued at Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Healthcare Asset Management Market By Technology (RFID, Real-Time Location Systems, Barcode, Infrared & Ultrasound, IoT); By Application (Equipment Tracking, Inventory Management, Patient Tracking, Workflow Optimization, Compliance Management); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Clinical Labs & Pharmacies, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Healthcare Asset Management Market growing at 12.6% CAGR, expanding from USD 16.3 billion in 2024 to USD 33.5 billion by 2030, driven by hospital ... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Neurogenic Bladder Infections Market By Product Type (Pharmacological Therapies, Medical Devices, Diagnostics); By Treatment Modality (Oral Therapies, Intravesical Therapy, Catheter-Based Interventions); By End User (Hospitals, Rehabilitation Centers, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Neurogenic Bladder Infections Market: Recurrent UTI Burden Shifts Value Toward Reimbursed Catheter Systems and Specialist Prevention

 

The Global Neurogenic Bladder Infections Market is estimated to reach USD 4.05 billion in 202... Read More

Published Date: JUL-2026 | No Of Pages:156 | $ 4485

Opioid Receptor Agonist Market By Product Type (Full Agonists, Partial Agonists, Mixed Agonist-Antagonists); By Receptor Type (Mu, Kappa, Delta); By Route of Administration (Oral, Injectable, Transdermal, Nasal, Sublingual); By End User (Hospitals, Retail Pharmacies, Rehabilitation Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Opioid Receptor Agonist Market is poised for moderate expansion, reaching an estimated USD 21.6 billion in 2024, with projections hitting USD 29.1 billion by 2030, reflect... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Rectal Catheters Market By Product Type (Balloon Catheters, Flexi-Tip Catheters, Standard Rectal Tubes); By Application (Fecal Incontinence Management, Critical Care, Medication Administration/Enema); By End User (Hospitals, Long-Term Care Facilities, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rectal Catheters Market is projected to grow at a CAGR of 5.6% between 2024 and 2030. It’s currently valued at USD 680.0 million in 2024Read More

Published Date: JAN-2026 | No Of Pages:174 | $ 4485

Thr-β Agonist Market By Fibrosis Stage (F2, F3); By Diagnosis Pathway (Biopsy-Confirmed, NIT-Confirmed); By Treatment Setting (Monotherapy, Combination Therapy); By Geography, Segment Revenue Estimation, Forecast, 2025–2035

INTRODUCTION AND STRATEGIC CONTEXT

The Global Thr-β Agonist Market is set to expand rapidly between 2025 and 2035, growing from under $1 billion in 2025 to nearly $11 billion by 2030, according to Strategic Marke... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Fluorescent Antibody Test Market By Test Type (Direct Fluorescent Antibody Test, Indirect Fluorescent Antibody Test); By Product (Testing Kits, Fluorophore-Conjugated Antibodies, Microscopy Systems, Automated Slide Processors, Consumables); By Application (Autoimmune Disorder Diagnosis, Infectious Disease Testing, Rabies Surveillance, Veterinary Diagnostics, Research & Biotechnology); By End User (Hospitals, Clinical Laboratories, Reference Laboratories, Public Health Agencies, Research Institutes, Veterinary Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Fluorescent Antibody Test Market: Autoimmune IFA Automation, Rabies Surveillance, and Molecular Diagnostic Substitution Reshape Demand

The Global Fluorescent Antibody Test Market was valued at USD 1.72 billion in 2025 and is projected to reach USD 2.85 billion by 2032... Read More

Published Date: JUL-2026 | No Of Pages:163 | $ 4485

Integrase Inhibitors Market By Product Type (Oral Tablets, Combination Tablets, Long-Acting Injectables); By Application (First-Line Therapy, Treatment-Experienced Patients, Prophylaxis); By End User (Hospitals, HIV Care Centers, Outpatient Clinics, Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Integrase Inhibitors Market is projected to grow at a robust CAGR of 9.1 %, with an estimated market value of USD 12.3 billion in... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Robot-Assisted Percutaneous Coronary Intervention (PCI) Market By Product Type (Robotic-Assisted Systems, Robotic Catheters, Imaging Systems); By Application (Coronary Artery Disease, Peripheral Artery Disease, Other Cardiovascular Conditions); By End User (Hospitals, Specialized Cardiac Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market is poised for significant growth, with a robust CAGR of 10.4% from 2024 to 2030. The market was valued at Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Workplace Stress Management Market By Solution Type (Individual-Focused Tools, Organizational Programs, AI/Analytics-Based Platforms); By Service Delivery Model (In-House Programs, Third-Party Consulting, Digital Platforms, Hybrid Models); By End User (Large Enterprises, SMEs, Healthcare Providers, Government/Public Sector, Education Sector); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Workplace Stress Management Market projected to reach USD 16.8 billion by 2030 from USD 11.2 billion in 2024, registering 6.9% CAGR, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Cell Permeabilization Market By Product Type (Chemical-Based Agents, Physical Permeabilization Tools, Enzyme-Based Solutions); By Application (Intracellular Protein Detection, Gene Transfection, Drug Discovery, Microbial Cell Studies); By End User (Academic & Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Permeabilization Market will experience a steady CAGR of 6.8%, valued at USD 768 million in 2024, and expected to cross USD 1.14 billion by 2030, acc... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Luciferase Assay Market By Assay Type (Single Luciferase Assay, Dual Luciferase Assay, Multiplex Luciferase Assay); By Application (Drug Discovery & Development, Gene Expression Analysis, Cancer Research, Virology & Vaccines); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Luciferase Assay Market is projected to grow at a CAGR of 6.9%, reaching an estimated USD 4.7 billion by 2030, up from USD 2.9 billion in 2024, according ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Immunogenetics Market By Product Type (Diagnostic Assays, Reagents & Consumables, Instruments & Platforms); By Application (Transplantation Genotyping, Autoimmune Diagnostics, Pharmacogenomics & Immunotherapy, Infectious Disease Susceptibility); By Technology (PCR, NGS, Microarray); By End User (Hospitals & Transplant Centers, Clinical Reference Labs, Academic & Research Institutes, Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immunogenetics Market is projected to grow at a robust CAGR of 8.9%, climbing from an estimated USD 5.8 billion in 2024 to USD 10.4 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Biological Imaging Reagents Market By Product Type (Fluorescent Dyes & Probes, Enzymes & Substrates, Antibodies & Proteins, Kits & Consumables); By Application (Cellular Imaging, Molecular Imaging, Diagnostics, Drug Discovery & Development); By End User (Research Laboratories, Biopharmaceutical Companies, Hospitals & Clinical Laboratories, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biological Imaging Reagents Market valued at USD 5.2 billion in 2024 and projected to reach USD 8.1 billion by 2030 at 6.8% CAGR, driven by life s... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Chromatography Reagents Market By Type (Solvents, Buffers, Derivatization Reagents, Ion-Pair Reagents, Other Functional Reagents); By Technique (Liquid Chromatography, Gas Chromatography, Thin Layer Chromatography, Others); By End User (Pharmaceutical & Biotechnology, Environmental Testing, Food & Beverage, Academic & Research Labs, CROs & CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatography Reagents Market valued at USD 7.9 billion in 2024 and projected to reach USD 11.5 billion by 2030 at 6.4% CAGR, driven by analytica... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Equilibrium Dialysis Market By Product Type (Multi-Well Equilibrium Dialysis Systems, Single-Use Devices, Consumables and Accessories); By Application (Drug–Protein Binding Studies, Plasma Protein Interaction Assessment, Metabolite Analysis, Bioavailability Optimization); By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations [CROs], Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Equilibrium Dialysis Market is anticipated to grow steadily at a CAGR of 6.8%, reaching USD 190 million by 2030, up from an estimated USD 120 million in 2024Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Cyclic Heavy Menstrual Bleeding (CHMB) Market By Treatment Type (Pharmacological Therapies, Surgical and Device-Based Therapies); By Cause (Uterine Fibroids, Hormonal Imbalance, Coagulopathy); By End User (Hospitals, Gynecology Clinics, Ambulatory Surgical Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclic Heavy Menstrual Bleeding (CHMB) Market is expected to expand steadily from 2024 to 2030, driven ... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Radiofrequency (RF) Microneedling Market By Component Type (Devices, Consumables); By Application (Skin Rejuvenation, Acne Scarring, Hyperpigmentation, Stretch Marks); By End User (Dermatology Clinics, Medical Spas, Hospitals, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiofrequency (RF) Microneedling Market is projected to expand at a robust CAGR of 11.3%, growing from an estimated Read More

Published Date: JAN-2026 | No Of Pages:161 | $ 4485

Genome Perturbation Tools Market By Tool Type (CRISPR Systems, RNAi, Transposons, Antisense Oligonucleotides, Morpholinos); By Application (Drug Discovery, Functional Genomics, Disease Modeling, Synthetic Biology); By Delivery Method (Viral Vectors, Lipid Nanoparticles, Electroporation/Nucleofection); By End User (Academic Institutions, Biotech & Pharma, CROs, Synthetic Biology Startups); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Genome Perturbation Tools Market is projected to expand at a CAGR of 9.8%, rising from an estimated USD 3.7 billion in 2024 to USD 6.6 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Cycloplegic Agents Market By Drug Type (Atropine-based Agents, Cyclopentolate-based Agents, Tropicamide-based Agents); By Application (Diagnostic Refraction, Myopia Management, Uveitis and Inflammatory Conditions, Pre/Post-Operative Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cycloplegic Agents Market will witness a steady CAGR of 5.8%, valued at around USD 540.0 million in 2024, and is expected to cross Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Medical Elastomer Market By Material Type (Thermoplastic Elastomers [TPEs], Silicone Elastomers, Thermoset Elastomers); By Application (Implantables, Drug Delivery Systems, Medical Tubing & Catheters, Diagnostics & Labware, Wearable Medical Devices); By End User (Medical Device Manufacturers, Pharmaceutical Companies, Diagnostic Labs, Hospitals & Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medical Elastomer Market valued at USD 7.5 billion in 2024 and projected to reach USD 11.2 billion by 2030 at 6.8% CAGR, driven by medical devices... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Agricultural Biotechnology Market By Product Type (Transgenic Seeds, Gene-Edited Seeds, Biopesticides & Biofertilizers, Synthetic Biology Inputs); By Technology (Genetic Engineering, Genome Editing, RNAi, Molecular Diagnostics, Tissue Culture); By Application (Crop Production, Soil & Plant Health, Animal Feed, Industrial Agriculture); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Agricultural Biotechnology Market is poised to grow at a strong CAGR of 9.6%, reaching a valuation of around USD 78.4 billion in 2024, an... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Transcriptomics Market By Technology (RNA Sequencing, Microarrays, qPCR, Spatial Transcriptomics, Single-cell RNA-seq); By Application (Drug Discovery, Clinical Diagnostics, Toxicogenomics, Academic Research); By End User (Pharmaceutical Companies, Academic Institutions, Clinical Laboratories, CROs, Startups); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transcriptomics Market expanding at 11.6% CAGR, moving from USD 9.8 billion in 2024 to USD 19.1 billion by 2030, supported by gene profilingRead More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Anthelmintic Drugs Market By Product Type (Benzimidazoles, Macrocyclic Lactones, Imidazothiazoles, Others); By Route of Administration (Oral, Injectable, Topical); By End User (Hospitals/Clinics, Public Health Programs, Livestock Farms, Poultry & Aquaculture, Companion Animal Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anthelmintic Drugs Market valued at USD 4.2 billion in 2024 and projected to reach USD 6.0 billion by 2030 at 5.8% CAGR, driven by parasitic infec... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Multidrug-Resistant Bacteria Market By Drug Class (Beta-lactam Combinations, Oxazolidinones & Glycopeptides, Tetracyclines & Derivatives, Polymyxins, Others [Phage Therapy, CRISPR-based Antimicrobials, Novel Peptides]); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Anaerobic and Atypical Pathogens); By Application Setting (Hospital-Acquired Infections, Community-Acquired Infections, Long-Term Care & Post-Acute Care, Military, Emergency, and Trauma Care); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Multidrug-Resistant Bacteria Market: AMR Mortality, Gram-Negative Resistance, and New Antibiotic Approvals Rebuild the Value of Anti-Infective Innovation

The Global Multidrug-Resistant Bacteria Market was valued at USD 13.5 billion in 2025 and is projected to reach US... Read More

Published Date: JUN-2026 | No Of Pages:154 | $ 4485

Skin Microbiome Market By Product Type (Probiotic Skincare, Prebiotic Skincare, Postbiotic Formulations, Microbiome Therapeutics); By Application (Cosmetic Skincare, Medical Dermatology, Personal Hygiene); By End User (Consumers, Dermatology Clinics, Pharmaceutical & Biotech Companies, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Microbiome Market valued at USD 1.98 billion in 2024 and projected to reach USD 4.52 billion by 2030 at 14.6% CAGR, driven by skincare innova... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Sterilization Equipment Market By Product Type (Steam Sterilizers, Low-Temperature Sterilizers, Ethylene Oxide (EtO) Sterilizers, Radiation-Based Sterilizers); By Application (Healthcare Facilities, Pharmaceutical & Biotechnology, Food Processing, Cosmetics Manufacturing); By End User (Hospitals & Clinics, Contract Sterilization Providers, Medical Device Manufacturers, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sterilization Equipment Market valued at USD 13.2 billion in 2024 and reaching USD 19.8 billion by 2030 at 7.1% CAGR, driven by medical devicesRead More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Gastric Ulcer Treatment Market By Treatment Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blockers, H2-Receptor Antagonists, Antibiotic Combination Therapies, Bismuth-Based Therapies, Mucosal Protective Agents, Antacids, Endoscopic Treatment, Surgical Treatment); By Application (Helicobacter pylori-Associated Gastric Ulcers, NSAID-Induced Gastric Ulcers, Bleeding Gastric Ulcers, Refractory Gastric Ulcers, Recurrent Gastric Ulcers, Perforated Gastric Ulcers, Stress-Related Gastric Ulcers); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Endoscopy Centers, Primary Care Clinics, Retail Pharmacies, Hospital and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Gastric Ulcer Treatment Market: Resistance-Aware H. pylori Therapy, Follow-Up Care, and Payer Access Redirect Revenue

The Global Gastric Ulcer Treatment Market was valued at USD 5.63 billion in 2025 and is projected to reach USD 8.57 billion by 2032, growing at a CAGR... Read More

Published Date: JUL-2026 | No Of Pages:195 | $ 4485

VMAT2 Inhibitors Market by Application (Parkinson’s Disease, Huntington’s Disease, Tardive Dyskinesia, Other Neurological Disorders); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global VMAT2 Inhibitors Market is set to grow significantly, driven by advancements in neurological therapeutics and an increasing understanding of neurological disorders. As of 2024, the market ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Alkylating Agents Market By Product Type (Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazenes, Others); By Route of Administration (Intravenous, Oral); By Application (Hematological Malignancies, Solid Tumors, Others); By End User (Hospitals, Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alkylating Agents Market is projected to witness a robust CAGR of 6.4%, valued at USD 7.1 billion in 2024, and expected to reach USD 10.4 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Povidone Iodine Market By Product Type (Scrub Solution, Ointment, Gargle, Swabs, Others); By Formulation (Liquid, Powder, Ointment, Spray); By Application (Wound Care, Surgical Disinfection, Oral Care, Gynecological Hygiene, Dermatology); By End User (Hospitals, Clinics, Pharmacies, NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Povidone Iodine Market is projected to reach approximately USD 920 million by 2030, growing from an estimated USD 640 million in 2024, at a steady Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Parenteral Packaging Market By Product Type (Vials, Prefilled Syringes, Ampoules, Cartridges, IV Bags); By Material (Glass, Plastic); By Drug Type (Vaccines, Biologics, Small Molecule Injectables); By End User (Pharmaceutical Companies, CMOs, Hospitals, Home Healthcare Settings); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Parenteral Packaging Market growing at 7.7% CAGR, from USD 15.8 billion in 2024 to USD 24.6 billion by 2030, driven by pharmaceutical packagingRead More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Pneumoconiosis Market By Disease Type (Coal Workers’ Pneumoconiosis, Silicosis, Asbestosis); By Diagnostic Tool (Chest X-ray, High-Resolution CT, Pulmonary Function Tests, AI Screening Software); By Treatment Modality (Oxygen Therapy, Bronchodilators & Anti-inflammatory Drugs, Anti-fibrotic Agents, Pulmonary Rehabilitation); By End User (Occupational Health Clinics, Public Hospitals, Respiratory Care Centers, Mobile Screening Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pneumoconiosis Market valued at USD 2.3 billion in 2024 and projected to reach USD 3.1 billion by 2030 at 5.1% CAGR, driven by occupational lung d... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Tularemia Therapeutics Market By Product Type (Antibiotics, Novel Therapeutics); By Route of Administration (Oral, Intravenous, Intramuscular); By End User (Hospitals, Public Health Agencies, Military/Biodefense, Research Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Tularemia Therapeutics Market: Updated Treatment Guidance, Outbreak Volatility, and Biodefence Preparedness Reshape Commercial Value

The Global Tularemia Therapeutics Market is estimated at USD 155.0 million in 2025 and is projected t... Read More

Published Date: JUL-2026 | No Of Pages:167 | $ 4485

Galectin Inhibitor Therapeutics Market By Type (Small Molecule Inhibitors, Monoclonal Antibodies, Glycomimetics); By Indication (Oncology, Fibrosis, Inflammatory and Autoimmune Disorders); By Route of Administration (Oral, Intravenous); By End User (Specialty Cancer Centers, Hepatology Clinics, Academic Research Hospitals, Community Oncology Networks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Galectin Inhibitors Market Advances Across Fibrosis, Oncology & Immune-Mediated Disease Pipelines (Last Updated on: June-2026)

The Global Galectin Inhibitor Therapeutics Market will witness a robust CAGR of 24.8%, valued at USD 0.67 b... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Powered Morcellator Market By Product Type (Reusable Morcellators, Disposable Morcellators); By Application (Gynecology, Urology, General Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Powered Morcellator Market is poised to expand steadily, with a projected CAGR of 6.8%, valued at USD 1.2 billion in 2024 and expected to reach USD 1.8 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Cannabis Pharmaceuticals Market By Product Type (Cannabidiol [CBD], Tetrahydrocannabinol [THC], Combination Cannabinoids, Synthetic Cannabinoids); By Route of Administration (Oral, Inhalation, Topical, Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Pharmaceuticals Market valued at USD 3.9 billion in 2024 and projected to reach USD 10.3 billion by 2030 at 17.6% CAGR, driven by pharmac... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

WNT Signaling Pathway Inhibitor Market By Type of Inhibitor (Small Molecule Inhibitors, Monoclonal Antibodies, Other Biologics); By Application (Oncology, Bone Diseases, Neurodegenerative Diseases); By End-User (Hospitals, Research Institutions, Specialized Cancer Centers, Diagnostic Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Wnt Signaling Inhibitors Market Advances Through Precision Oncology Pipelines Targeting β-Catenin, DKK1 and PORCN Biology (Last Updated on: June-2026)

The Global WNT Signaling Pathway Inhibitor Market is projected to grow from USD 2.8 billion in 2024 to USD 6.1 b... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Nasal Aspirate Testing Market By Test Type (Molecular Testing, Immunoassay Testing, Culture-Based Testing); By End User (Hospitals, Diagnostic Laboratories, Pediatric Clinics, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nasal Aspirate Testing Market valued at USD 1.2 billion in 2024 and projected to reach USD 2.4 billion by 2030 at 7.5% CAGR, driven by diagnostic ... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Lymphangioleiomyomatosis Market By Type (Sporadic LAM, TSC-Associated LAM); By Treatment (Sirolimus, Everolimus, Supportive Therapy, Lung Transplantation); By Diagnostic Modality (HRCT Imaging, VEGF-D Testing, Genetic Testing); By End User (Tertiary Hospitals, Pulmonology Clinics, Diagnostic Labs, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphangioleiomyomatosis Market valued at USD 428 million in 2024 and projected to reach USD 610 million by 2030 at 6.1% CAGR, driven by rare dise... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Autoimmune Hepatitis Market By Disease Type (Type 1 Autoimmune Hepatitis, Type 2 Autoimmune Hepatitis, Seronegative Autoimmune Hepatitis); By Treatment Type (Corticosteroids, Conventional Immunosuppressants, Biologics & Targeted Therapies, Liver Transplant Interventions); By Diagnosis & Monitoring Method (Autoantibody Testing, IgG Quantification, Liver Function Testing, Liver Biopsy, Fibrosis Assessment Tools); By End User (Tertiary Care Hospitals, Specialty Clinics, Diagnostic Laboratories, Transplant Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Autoimmune Hepatitis Market: Lifelong Immunosuppression and Steroid-Sparing Innovation Expand a Focused Rare-Disease Opportunity

The Global Autoimmune Hepatitis Market is estimated at USD 183.99 million in 2025 and is projected to reach USD 228.13 million by 2032, exp... Read More

Published Date: JUL-2026 | No Of Pages:197 | $ 4485

Xenotransplantation Market By Product Type (Solid Organs [Kidney, Heart, Liver], Cellular & Tissue Transplants); By Application (End-Stage Organ Failure, Regenerative/Immunotherapy Applications); By End User (Hospitals & Transplant Centers, Research Institutes, Cellular Therapy Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Xenotransplantation Market projected to reach USD 2.7 billion by 2030 from USD 1.2 billion in 2024, registering 13.5% CAGR, supported by clinical ... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Peptide and Anticoagulant Drugs Market By Product Type (Peptide-based Therapies, Anticoagulants); By Application (Cardiovascular, Oncology, Neurology, Endocrine & Metabolic Disorders); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers [ASCs], Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peptide And Anticoagulant Drugs Market valued at USD 18.3 billion in 2024 and projected to reach USD 32.1 billion by 2030 at 6.5% CAGR, driven by ... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Vaginal Anti-Infectives Market By Product Type (Antifungal Agents, Antibacterial Formulations, Antiseptics, Probiotic-Based Products); By Infection Type (Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis, Mixed Infections); By Route of Administration (Topical, Oral, Vaginal Tablets & Suppositories); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginal Anti-Infectives Market is projected to grow steadily between 2024 and 2030, expanding from an estimated value of USD 3.1 billion in 2024 to nearly USD 4.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Uterotonic Agent Market By Product Type (Oxytocin-Based, Prostaglandins, Ergot Derivatives, Combination Therapies); By Route of Administration (Intravenous, Intramuscular, Oral, Sublingual); By End User (Hospitals, Maternity Clinics & Birthing Centers, Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uterotonic Agent Market will witness a robust CAGR of 6.8 %, valued at USD 2.1 billion in 2024, and is ... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Telestroke Services Market By Service Type (Ischemic Stroke Management, Hemorrhagic Stroke Management); By Component (Hardware, Software, Services); By Mode of Delivery (Web-Based, Cloud-Based, On-Premise); By End User (Hospitals, Telehealth Providers, Government & Public Health Agencies, Ambulatory & Specialty Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Telestroke Services Market valued at USD 1.6 billion in 2024 and projected to reach USD 2.9 billion by 2030 at 8.5% CAGR, driven by telemedicineRead More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Sulfonylureas Market By Drug Generation (First-Generation, Second-Generation); By Application (Type 2 Diabetes Mellitus, Obesity-linked Diabetes, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sulfonylureas Market projected to reach USD 3.1 billion by 2030 from USD 2.5 billion in 2024, registering 3.6% CAGR, supported by diabetes drugsRead More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Submental Fat Treatment Market By Treatment Modality (Injectables, Cryolipolysis, Laser, Radiofrequency, Surgical Liposuction); By End User (Dermatology Clinics, Plastic Surgery Centers, Medspas, Specialized Aesthetic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Submental Fat Treatment Market is projected to witness a robust CAGR of 12.1%, valued at USD 1.1 billion in 2024 and expected to reach USD 2.1 billion by 2030,Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Proctoscope Market By Product Type (Disposable Proctoscopes, Reusable Proctoscopes); By Illumination Type (LED-Illuminated, Fiber-Optic, Non-Illuminated); By Application (Hemorrhoid Diagnosis, Anal Fissure & Fistula Management, Rectal Polyp & Tumor Detection); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Proctoscope Market is projected to grow steadily at a CAGR of 5.6% , valued at around USD 412 million in 2024 , and estimated to reach Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Pleural Effusion Market By Type (Transudative Effusion, Exudative Effusion); By Treatment (Thoracentesis, Indwelling Pleural Catheter, Pleurodesis, Pharmacologic Management); By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pleural Effusion Market is projected to reach USD 1.82 billion by 2030 , rising from an estimated USD 1.25 billion in 2024 , expanding at a CAGR o... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Pericarditis Treatment Market By Treatment Type (Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, IL-1 Inhibitors, Immunosuppressive Therapies, Intravenous Immunoglobulin, Other Supportive Therapies); By Application (Acute Pericarditis, Recurrent Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Post-Pericardiotomy Syndrome); By End User (Hospitals, Specialty Cardiology Centers, Ambulatory Care Centers, Specialty Clinics, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Pericarditis Treatment Market: Recurrent Disease Shifts Revenue Toward Long-Duration Specialty Care

The Global Pericarditis Treatment Market was valued at USD 3.30 billion in 2025 and is projected to reach USD 5.41 billion by 2032, growing at a CAGR of 6.4%, according... Read More

Published Date: JUL-2026 | No Of Pages:191 | $ 4485

Optogenetics Market By Product Type (Channelrhodopsins, Halorhodopsins, Archaerhodopsins, Red-Shifted Opsins); By Light Source (Laser Systems, LED Systems, Fiber Optics, Wireless Optical Devices); By Application (Neuroscience, Retinal Disorders, Cardiology, Psychiatric and Behavioral Research); By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, Clinical and Translational Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Optogenetics Market valued at USD 780 million in 2024 and projected to reach USD 1.78 billion by 2030 at 14.8% CAGR, driven by neuroscience resear... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Ophthalmology Electronic Health Record (EHR) Market By Product Type (Cloud-Based, On-Premise); By Application (Retina Management, Glaucoma Management, Cataract Surgery Tracking, Corneal Diagnostics, Optometry Records); By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmology Electronic Health Record (EHR) Market will grow at a robust CAGR of 8.1% , valued at around USD 1.7 billion in 2024 and projected to reach n... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Onchocerciasis Treatment Market By Drug Class (Macrocyclic Lactones, Antibiotics, Anti-Wolbachia Agents); By Treatment Strategy (Mass Drug Administration, Selective/Targeted Treatment); By Distribution Model (Donation-Based, Government Procurement, NGO-Driven); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Onchocerciasis Treatment Market is poised to grow at a CAGR of 5.6% , rising from an estimated USD 297.5 million in 2024 to approximately... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Neuraminidase Inhibitors Market By Product Type (Oseltamivir, Zanamivir, Peramivir, Next-Generation Long-Acting Inhibitors); By Route of Administration (Oral, Inhalation, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Supply Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Neuraminidase Inhibitors Market Benefits from Seasonal Influenza Treatment Demand and Antiviral Stockpile Readiness (Last Updated On: June-2026)

The Global Neuraminidase Inhibitors Market was valued at USD 4.6 billion in 2024 and is projected to reach USD 7.1 bil... Read More

Published Date: Jun-2026 | No Of Pages:195 | $ 4485

Nerve Growth Factor Market By Product Type (Recombinant NGF Proteins, Natural NGF Extracts, Gene Therapy Vectors); By Application (Neurodegenerative Disorders, Ophthalmology, Wound Healing, Peripheral Nerve Regeneration); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Specialty Clinics, Contract Research & Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nerve Growth Factor Market valued at USD 3.2 billion in 2024 and projected to reach USD 5.1 billion by 2030 at 8.1% CAGR, driven by neurodege... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Nasal Polyposis Treatment Market By Treatment Type (Intranasal Corticosteroids, Oral Corticosteroids, Biologics, Endoscopic Sinus Surgery, Supportive Therapies); By Disease Severity (Mild to Moderate CRSwNP, Severe Uncontrolled CRSwNP); By Biologic Class (IL-4/IL-13 Inhibitors, Anti-IgE Therapy, IL-5 Inhibitors, TSLP Inhibitors, Other Pipeline Biologics); By End User (Hospitals, ENT Specialty Clinics, Allergy & Pulmonology Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Nasal Polyposis Treatment Market Benefits from Severe CRSwNP Biologic Expansion and Steroid-Sparing Treatment Demand

The Global Nasal Polyposis Treatment Market was valued at USD 4.94 billion in 2025 and is projected to reach USD 7.79 billion by 2032, growing at a CAG... Read More

Published Date: JUL-2026 | No Of Pages:198 | $ 4485

Mitotic Inhibitors Market By Drug Class (Vinca Alkaloids, Taxanes, Others); By Application (Breast Cancer, Lung Cancer, Ovarian Cancer, Leukemia & Lymphoma, Other Solid Tumors); By Route of Administration (Intravenous, Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Mitotic Inhibitors Market: Established Oncology Use, Generic Expansion, and Emerging Mitotic-Targeted Therapies (Last Updated on: June-2026)

The Global Mitotic Inhibitors Market is projected to expand at a CAGR of 5.9%, with an estimated valua... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Meglitinides Market By Molecule Type (Repaglinide, Nateglinide); By Formulation (Monotherapy Tablets, Fixed-Dose Combinations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meglitinides Market is projected to reach USD 754 million by 2030 , up from an estimated USD 520 million in 2024 , growing at a C... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Lysosomal Enzymes Market By Type (Acid Hydrolases, Proteases, Glycosidases, Lipases); By Disease Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis [MPS I, II, VI], Others); By Source (Human Recombinant Systems, Animal Cell Culture, Microbial Expression Systems); By End User (Pharmaceutical & Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals & Clinical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lysosomal Enzymes Market is projected to register a steady CAGR of 6.5% , valued at around USD 7.8 billion in 2024 and expected to reach nearly USD 12.1 billion by... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Leukotriene Inhibitors Market By Drug Type (Montelukast, Zafirlukast, Pranlukast, Others); By Application (Asthma, Allergic Rhinitis, Chronic Urticaria, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leukotriene Inhibitors Market is projected to grow at a steady pace, rising from an estimated USD 1.62 billion in 2024 to approximately USD 2.31 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Keratolytic Agents Market By Product Type (Salicylic Acid, Urea, Alpha Hydroxy Acids, Lactic Acid, Sulfur Compounds, Others); By Formulation Type (Topical Creams & Ointments, Gels & Serums, Medicated Shampoos, Patches & Plasters, Liquid Solutions & Peels); By Application (Dermatological Disorders, Cosmetic Exfoliation & Skincare, Wart & Callus Removal, Foot Care, Scalp and Hair Treatment, Veterinary & Niche Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Keratolytic Agents Market is projected to expand at a CAGR of 5.8% , rising from an estimated $1.12 billion in 2024 to reach approximately $1.58 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Polyclonal Antibodies Market By Source (Rabbit, Goat, Sheep, Others); By Application (Research, Diagnostics, Therapeutics, Veterinary); By End User (Academic & Research Institutes, Pharmaceutical & Biotech Companies, Diagnostics Manufacturers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Polyclonal Antibodies Market valued at USD 2.34 billion in 2024 and projected to reach USD 3.3 billion by 2030 at 5.9% CAGR, driven by biopharmace... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Uterine Fibroid Embolization Devices Market By Product Type (Embolic Agents, Microcatheters, Guidewires, Delivery Syringes); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Office-Based Labs); By Patient Profile (Women aged 30–50, Fertility-Preserving Candidates, High-Risk Surgical Patients); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uterine Fibroid Embolization Devices Market is projected to grow at a CAGR of 8.6%, valued at USD 1.2 billion in 2024, and expected to reach USD 2... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Organ Function Assays Market By Test Type (Liver Function Tests, Renal Function Tests, Cardiac Function Tests, Pulmonary Function Tests, Thyroid Function Tests); By Technology (Immunoassays, Chemiluminescence & Colorimetric Assays, Enzymatic & Spectrophotometric, Point-of-Care Devices); By End User (Hospitals & Clinical Labs, Ambulatory Surgical Centers, Diagnostic Chains, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Organ Function Assays Market will witness a steady CAGR of 6.5%, valued at USD 4.1 billion in 2024, and projected to reach USD 6.0 billion by 2030, accord... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Stereotactic X-ray Market By Technology Type (Frame-Based Stereotactic Systems, Frameless Image-Guided Systems); By Application (Oncology, Functional Neurosurgery, Spinal Interventions, Pain Management, Biopsy and Localization); By End User (Hospitals and Academic Centers, Specialty Cancer Centers, Outpatient Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stereotactic X-Ray Market is projected to grow at a steady pace, expected to reach USD 2.1 billion by 2030, up from USD 1.4 billion in 2024, reflecting a CAGR of 6... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Emergency Escape Breathing Device Market By Product Type (Hooded EEBDs, Full-Face Mask Devices, Mouthpiece-Only Devices); By End User (Maritime & Offshore, Industrial Manufacturing, Mining & Tunneling, Public Infrastructure & Commercial Buildings, Emergency Services); By Duration (Short-Duration EEBDs, Medium-Duration EEBDs, Extended-Duration EEBDs); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Emergency Escape Breathing Device Market: Safeguarding Lives in Critical Industrial Environments

The Global Emergency Escape Breathing Device Market was valued at USD 1.19 billion in 2025 and is projected to reach USD 2.10 billion by 2032, exp... Read More

Published Date: AUG-2026 | No Of Pages:166 | $ 4485

Reporter Tags Market By Tag Type (Fluorescent Tags, Enzymatic Tags, Epitope Tags, Radioactive & Chemiluminescent Tags); By Application (Gene Expression Analysis, Drug Screening, Protein Localization, Synthetic Biology, Biomarker Discovery); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Diagnostic Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Reporter Tags Market valued at USD 880 million in 2024 and projected to reach USD 1.46 billion by 2030 at 8.7% CAGR, driven by biotechnology resea... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Pelvic Organ Prolapse Repair Market By Product Type (Synthetic Mesh, Biologic Implants, Pessaries, Suturing Kits); By Procedure Type (Vaginal Repair, Laparoscopic Repair, Robotic-Assisted Repair, Abdominal Repair); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, OB-GYN Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pelvic Organ Prolapse Repair Market valued at USD 2.1 billion in 2024 and projected to reach USD 3.4 billion by 2030 at 8.3% CAGR, driven by pelvi... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Inactivated Vaccines Market By Vaccine Type (Whole Virus Inactivated, Split/Subunit, Toxoid); By Indication (Polio, Hepatitis A, Rabies, Influenza, Combination Vaccines); By End User (Public Health Programs, Pediatric Clinics, Travel Clinics, Military & Occupational Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inactivated Vaccines Market projected to reach USD 33.7 billion by 2030 from USD 22.7 billion in 2024, registering 6.8% CAGR, supported by vaccina... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Saphenous Vein Grafts Market By Application (Coronary Artery Bypass Grafting, Peripheral Vascular Bypass, Carotid Endarterectomy Support); By Harvesting Technique (Open Vein Harvesting, Endoscopic Vein Harvesting); By End User (Hospitals, Cardiac Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Saphenous Vein Grafts Market is projected to expand at a steady pace, with an estimated valuation of USD 543.7 million in 2024, and anticipated to reach around USD... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Aldose Reductase Inhibitor Market By Drug Type (Epalrestat, Ranirestat, Fidarestat, Investigational ARIs); By Application (Diabetic Neuropathy, Diabetic Retinopathy, Diabetic Nephropathy, Others); By Route of Administration (Oral, Topical, Injectable); By End User (Hospitals, Specialty Clinics, Diabetic Care Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aldose Reductase Inhibitor Market will witness a steady CAGR of 7.9%, valued at USD 610.0 million in 2024, and expected to reach around <... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Spinal Machined Bone Allograft Market By Graft Type (Cervical Machined Allograft, Thoracolumbar Machined Allograft); By Shape & Preparation (Blocks, Wedges, Plugs, Cages; Freeze-Dried, Fresh-Frozen, Carrier-Based); By End User (Hospitals, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Machined Bone Allograft Market will expand at a projected CAGR of 6.7%, reaching an estimated USD 1.96 billion by 2030, up from USD 1.31 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Archaeosomes Market By Product Type (Synthetic Archaeosomes, Natural Archaeosomes); By Application (Vaccine Delivery, Cancer Immunotherapy, Gene Therapy, Oral Drug Delivery, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CDMOs, Government & Nonprofit Research Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Archaeosomes Market is poised for steady growth, with an estimated value of USD 143.7 million in 2024, projected to reach USD 271.2 million by 203... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Blocking Buffers Market By Type (Protein-Based, Synthetic, Serum-Based/Hybrid); By Application (Western Blotting, ELISA, Immunohistochemistry, Flow Cytometry); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Clinical Diagnostics Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blocking Buffers Market will grow at a steady CAGR of 6.5%, valued at USD 1.2 billion in 2024 and projected to reach USD 1.77 billion by 2030, according t... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Radiation Proctitis Market By Treatment Type (Medications, Endoscopic Therapies, Surgical Interventions); By Route of Administration (Oral, Rectal, Intravenous); By End User (Hospitals & Specialty Oncology Centers, Outpatient Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiation Proctitis Market will witness a steady CAGR of 5.9%, valued at $494 million in 2024, expected to reach $701 million by 2030, confirms St... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Cardiovascular Genetic Testing Market By Test Type (Single-Gene Testing, Multi-Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing); By Application (Cardiomyopathies, Channelopathies, Aortic Disorders, Familial Hypercholesterolemia, Congenital Heart Disease, Sudden Cardiac Death Risk); By End User (Hospitals & Cardiology Clinics, Diagnostic Laboratories, Academic & Research Institutions, Direct-to-Consumer Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Genetic Testing Market will witness a strong CAGR of 11.7%, valued at USD 2.6 billion in 2024, and is expected to reach around USD 5.1 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485